## MMC: Marsh & McLennan Companies, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.3% below STRENGTH zone (4.0-10.0%); PEG 1.85 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($180.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Voya Investment Management LLC Sells 74,363 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251221T121924 | Neutral | Relevance: 100%
- Voya Investment Management LLC reduced its stake in Marsh & McLennan Companies (NYSE:MMC) by 25.7% during the third quarter, selling 74,363 shares. The firm now owns 214,568 shares worth approximately $43.24 million. Other institutional investors have also adjusted their holdings, while CEO John Q. Doyle recently sold 21,079 shares of the company's stock.

**2. Marsh & McLennan Companies, Inc. $MMC Stock Position Boosted by Louisbourg Investments Inc.**
- Source: MarketBeat | 20251220T115222 | Bullish | Relevance: 100%
- Louisbourg Investments Inc. significantly increased its stake in Marsh & McLennan Companies (NYSE:MMC) by 170% in Q3, now owning 14,794 shares valued at $2.98 million. This comes as CEO John Q. Doyle sold a portion of his holdings, reducing his ownership by 19.38%. Despite the insider selling, institutional investors collectively own a substantial 87.99% of the company, which recently beat Q3 earnings estimates with an EPS of $1.85 and an 11.5% revenue increase.

**3. Sarasin & Partners LLP Buys 367,121 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251221T130816 | Neutral | Relevance: 100%
- Sarasin & Partners LLP increased its stake in Marsh & McLennan Companies by 65.6% during the third quarter, acquiring an additional 367,121 shares to own a total of 926,449 shares valued at approximately $185.5 million. The financial services provider reported strong Q3 earnings with an EPS of $1.85 and revenue of $6.35 billion, surpassing analyst expectations. The article also notes recent insider selling by CEO John Q. Doyle and updated analyst ratings, with an average target price of $222.35 for MMC.

**4. Flputnam Investment Management Co. Trims Stake in Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251221T114706 | Neutral | Relevance: 100%
- Flputnam Investment Management Co. reduced its stake in Marsh & McLennan Companies, Inc. by 22.2% in Q3, now holding 167,968 shares valued at $33.85 million. This follows CEO John Q. Doyle's sale of 21,079 shares, decreasing his stake by 19.38%. Despite these insider movements, analysts maintain a consensus "Hold" rating with a target price of $222.35, following the company's Q3 earnings beat and 11.5% year-over-year revenue growth.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $212 | $0 | 0% |
| 2025-12-04 | Citigroup | $201 | $211 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-04 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.28M) |
| Sells | 1 ($3.84M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 7.9% (-3.7%)
- State Street Corpora: 4.4% (+0.4%)
- Capital Internationa: 3.8% (+1.2%)
- Capital World Invest: 3.6% (+0.5%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Long-term trend broken: trading 11.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.85 elevated, pricing in significant growth expectations. Forward P/E 18.0x stretched relative to 7% growth. Quality metrics strong (ROE 29%, margin 16%). Balance sheet: $2.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.2B |
| Beta | 0.75 |
| 52W Range | $174.18 - $248.00 |
| Short Interest | 1.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.85 |
| Forward P/E | 18.0 |
| Current P/E | 19.3 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.7% to 0.3% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.7pp (needs >4.0% for momentum thesis). MRS_5 (-1.6%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.89x), long-term trend not supportive. RSI neutral at 54. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.32% (CS: 50) | Neutral |
| RSI_14 | 53.7 | Neutral |
| MACD Histogram | 0.48 | Bullish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.006x | Above |
| vs SMA200 | 0.888x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $185.39
- **Stop Loss:** $180.01 (2.9% risk)
- **Target:** $190.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 167
- **Position Value:** $30,960.13
- **Portfolio %:** 30.96%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-29 (Est: $1.97)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $1.85 | +4.1% |
| 2025Q2 | $2.66 | $2.72 | +2.1% |
| 2025Q1 | $3.00 | $3.06 | +2.1% |
| 2024Q4 | $1.76 | $1.87 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*